[English] 日本語
Yorodumi- EMDB-23575: Structure of Plasmodium falciparum 20S proteasome with bound MPI-5 -
+Open data
-Basic information
Entry | Database: EMDB / ID: EMD-23575 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | Structure of Plasmodium falciparum 20S proteasome with bound MPI-5 | |||||||||
Map data | Structure of Plasmodium falciparum 20S proteasome with bound ML052 | |||||||||
Sample |
| |||||||||
Function / homology | Function and homology information Cross-presentation of soluble exogenous antigens (endosomes) / : / Orc1 removal from chromatin / CDK-mediated phosphorylation and removal of Cdc6 / KEAP1-NFE2L2 pathway / UCH proteinases / Ub-specific processing proteases / Neddylation / Antigen processing: Ubiquitination & Proteasome degradation / Neutrophil degranulation ...Cross-presentation of soluble exogenous antigens (endosomes) / : / Orc1 removal from chromatin / CDK-mediated phosphorylation and removal of Cdc6 / KEAP1-NFE2L2 pathway / UCH proteinases / Ub-specific processing proteases / Neddylation / Antigen processing: Ubiquitination & Proteasome degradation / Neutrophil degranulation / proteasome core complex / proteasome endopeptidase complex / proteasome core complex, beta-subunit complex / proteasome core complex, alpha-subunit complex / threonine-type endopeptidase activity / proteasomal protein catabolic process / ubiquitin-dependent protein catabolic process / proteasome-mediated ubiquitin-dependent protein catabolic process / endopeptidase activity / hydrolase activity / nucleus / cytosol / cytoplasm Similarity search - Function | |||||||||
Biological species | Plasmodium falciparum (malaria parasite P. falciparum) / Plasmodium falciparum (isolate 3D7) (eukaryote) | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.1 Å | |||||||||
Authors | Hanssen E / Liu B / Leis AP / Xie SC / Morton CJ / Metcalfe RD / Tilley L / Griffin MDW | |||||||||
Funding support | Australia, United States, 2 items
| |||||||||
Citation | Journal: Proc Natl Acad Sci U S A / Year: 2021 Title: Design of proteasome inhibitors with oral efficacy in vivo against and selectivity over the human proteasome. Authors: Stanley C Xie / Riley D Metcalfe / Hirotake Mizutani / Tanya Puhalovich / Eric Hanssen / Craig J Morton / Yawei Du / Con Dogovski / Shih-Chung Huang / Jeffrey Ciavarri / Paul Hales / Robert ...Authors: Stanley C Xie / Riley D Metcalfe / Hirotake Mizutani / Tanya Puhalovich / Eric Hanssen / Craig J Morton / Yawei Du / Con Dogovski / Shih-Chung Huang / Jeffrey Ciavarri / Paul Hales / Robert J Griffin / Lawrence H Cohen / Bei-Ching Chuang / Sergio Wittlin / Ioanna Deni / Tomas Yeo / Kurt E Ward / Daniel C Barry / Boyin Liu / David L Gillett / Benigno F Crespo-Fernandez / Sabine Ottilie / Nimisha Mittal / Alisje Churchyard / Daniel Ferguson / Anna Caroline C Aguiar / Rafael V C Guido / Jake Baum / Kirsten K Hanson / Elizabeth A Winzeler / Francisco-Javier Gamo / David A Fidock / Delphine Baud / Michael W Parker / Stephen Brand / Lawrence R Dick / Michael D W Griffin / Alexandra E Gould / Leann Tilley / Abstract: The proteasome is a potential antimalarial drug target. We have identified a series of amino-amide boronates that are potent and specific inhibitors of the 20S proteasome (20S) β5 active site and ...The proteasome is a potential antimalarial drug target. We have identified a series of amino-amide boronates that are potent and specific inhibitors of the 20S proteasome (20S) β5 active site and that exhibit fast-acting antimalarial activity. They selectively inhibit the growth of compared with a human cell line and exhibit high potency against field isolates of and They have a low propensity for development of resistance and possess liver stage and transmission-blocking activity. Exemplar compounds, MPI-5 and MPI-13, show potent activity against infections in a SCID mouse model with an oral dosing regimen that is well tolerated. We show that MPI-5 binds more strongly to 20S than to human constitutive 20S (20Sc). Comparison of the cryo-electron microscopy (EM) structures of 20S and 20Sc in complex with MPI-5 and 20S in complex with the clinically used anti-cancer agent, bortezomib, reveal differences in binding modes that help to explain the selectivity. Together, this work provides insights into the 20S proteasome in , underpinning the design of potent and selective antimalarial proteasome inhibitors. | |||||||||
History |
|
-Structure visualization
Movie |
Movie viewer |
---|---|
Structure viewer | EM map: SurfViewMolmilJmol/JSmol |
Supplemental images |
-Downloads & links
-EMDB archive
Map data | emd_23575.map.gz | 213.3 MB | EMDB map data format | |
---|---|---|---|---|
Header (meta data) | emd-23575-v30.xml emd-23575.xml | 35.2 KB 35.2 KB | Display Display | EMDB header |
FSC (resolution estimation) | emd_23575_fsc.xml | 10.6 KB | Display | FSC data file |
Images | emd_23575.png | 137.3 KB | ||
Others | emd_23575_additional_1.map.gz emd_23575_half_map_1.map.gz emd_23575_half_map_2.map.gz | 91.2 MB 91.1 MB 91.1 MB | ||
Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-23575 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-23575 | HTTPS FTP |
-Related structure data
Related structure data | 7lxuMC 7lxtC 7lxvC M: atomic model generated by this map C: citing same article (ref.) |
---|---|
Similar structure data |
-Links
EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
---|---|
Related items in Molecule of the Month |
-Map
File | Download / File: emd_23575.map.gz / Format: CCP4 / Size: 244.1 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Structure of Plasmodium falciparum 20S proteasome with bound ML052 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 1.31 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
CCP4 map header:
|
-Supplemental data
-Additional map: Additional map
File | emd_23575_additional_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Additional map | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: half-volume 1
File | emd_23575_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | half-volume 1 | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: half-volume 2
File | emd_23575_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | half-volume 2 | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Sample components
+Entire : Plasmodium falciparum 20S proteasome complexed with ML052
+Supramolecule #1: Plasmodium falciparum 20S proteasome complexed with ML052
+Macromolecule #1: 20S proteasome alpha-1 subunit
+Macromolecule #2: 20S proteasome alpha-2 subunit
+Macromolecule #3: 20S proteasome alpha-3 subunit
+Macromolecule #4: 20S proteasome alpha-4 subunit
+Macromolecule #5: 20S proteasome alpha-5 subunit
+Macromolecule #6: 20S proteasome alpha-6 subunit
+Macromolecule #7: 20S proteasome alpha-7 subunit
+Macromolecule #8: 20S proteasome beta-1 subunit
+Macromolecule #9: 20S proteasome beta-2 subunit
+Macromolecule #10: 20S proteasome beta-3 subunit
+Macromolecule #11: 20S proteasome beta-4 subunit
+Macromolecule #12: 20S proteasome beta-5 subunit
+Macromolecule #13: 20S proteasome beta-6 subunit
+Macromolecule #14: 20S proteasome beta-7 subunit
+Macromolecule #15: N-[(1R)-2-([1,1'-biphenyl]-4-yl)-1-boronoethyl]-1-methyl-L-prolinamide
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
Processing | single particle reconstruction |
Aggregation state | particle |
-Sample preparation
Buffer | pH: 7.4 |
---|---|
Grid | Model: Quantifoil R1.2/1.3 / Material: GOLD / Mesh: 300 / Support film - Material: GOLD / Pretreatment - Type: GLOW DISCHARGE |
Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 295 K / Instrument: FEI VITROBOT MARK III |
-Electron microscopy
Microscope | FEI TALOS ARCTICA |
---|---|
Electron beam | Acceleration voltage: 200 kV / Electron source: FIELD EMISSION GUN |
Electron optics | C2 aperture diameter: 50.0 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELDBright-field microscopy |
Image recording | Film or detector model: GATAN K2 SUMMIT (4k x 4k) / Detector mode: SUPER-RESOLUTION / Average electron dose: 50.0 e/Å2 |
Experimental equipment | Model: Talos Arctica / Image courtesy: FEI Company |